Charles S. Baldwin, IV

Partner, Brooks, Pierce, McLendon, Humphrey & Leonard, LLP

Charles S. Baldwin, IV is a partner at Brooks, Pierce, McLendon, Humphrey & Leonard, LLP. Mr. Baldwin assists his clients to grow globally. His law practice is concentrated in corporate and international law, representing companies across a broad range of industries, including consumer goods, technology, health care, manufacturing, pharmaceuticals, real estate, and port development. He also regularly advises investors on start-up and private equity issues, and is a frequent speaker and writer on business law and international trade matters.

Leah - Leah Burton.jpg

Leah Burton

Director, Centennial Campus Partnership Office, & Industry Alliances Office of Partnerships & Economic Development at North Carolina State University

Leah Burton is the Director of Centennial Campus Partnerships and Industry Alliances at NC State University. In this role, she manages the campus-wide strategy for corporate and government interactions with NC State, including the University’s award-winning Centennial Campus. Leah has a proven track record of building broad-based and sustainable industry-university partnerships and she has a passion for the value created when a successful collaboration is brokered.

Crenshaw_Headshot_square 300 pixels - hccrenshaw.png

Hugh Crenshaw

CEO, Physcient, Inc.

Hugh is CEO and co-founder at Physcient, Inc., a start-up in Durham, NC developing new surgical instruments. Hugh trained as a biologist and engineer with expertise in biomechanics and advanced instrumentation for biological research. Previously, he was Director of Microsystems Technology at GlaxoSmithKline, where he led programs in microfluidics and automated physiological measurement. Earlier, he was on faculty at Duke University (appointments in Zoology and Engineering) where he led teams in cell mechanics, underwater robotics, optical instrumentation, and microfluidics.

Bill Hawkins.png

William A. Hawkins III

Senior Advisor, EW Healthcare Partners

Mr. Hawkins is retired Chairman and CEO of Medtronic. He was recently elected to the National Academy of Engineering and is an AIMBE Fellow. He is a Senior Advisor to EW Healthcare Partners, a leading private equity firm investing in life sciences. Mr. Hawkins serves as a Director of Avanos Health NYSE: AVNS, Chairman of the Board of Bioventus, and 4Tech; and on the Board of Keratin Biosciences, Trice Medical, Virtue Labs, Baebies and AskBio. Mr. Hawkins is the past Chairman and Co-Founder of the Medical Device Innovation Consortium ("MDIC”) and past-president of the American Institute of Medical and Biological Engineering ("AMIBE"). He also sits on the Duke University Board of Trustees in 2011, Chair of the Board of the Duke University Health System and Member of the Advisory Boards at Arboretum Ventures, Hatteras Venture Partners, HealthQuest Ventures, and he is a member of the Biomedical Sciences International Advisory Council, Singapore (“BMS IAC”).

ALB HEadshotv3 - Allison London Brown.jpg

Allison London Brown

CEO, UVision360

Ms. London Brown has 20+ years of diverse experience spanning medical device, HCIT, consumer and biologics. During her career, she has launched over 90 products/services in organizations such as J&J, GEHC and various start-ups. Allison leads UVision360, Inc., developer of the LUMINELLE DTx Hysteroscopy System, a compact office-based femtech system. She serves as a Board Member for CED and Plakous Therapeutics and is a speaker for Women in STEM, Leadership and Strategy.

PaulMillman 2015.05_med res crop2 - Paul M..jpg

Paul Millman

VP, Advanced Product Development, Intuitive Surgical, Inc.

Paul Millman has been working in industry on the development of surgical robotic systems for over 22 years. He led teams that helped develop multiple generations of the da Vinci Surgical system, including the da Vinci Si system introduced in 2009, and the da Vinci Xi system launched in 2014. He currently focuses on cultivating early-stage technologies that can add value to Intuitive’s da Vinci product offering. He has an MS and Ph.D. in Mechanical Engineering from Northwestern University.


Bryant Moore

Director of Strategic Partnerships, Office of Technology Commercialization, University of North Carolina at Chapel Hill

Dr. Bryant Moore is Director, Strategic Partnerships at the University of North Carolina at Chapel Hill.  He joined UNC’s Office of Technology Commercialization in 2015 after a successful career of more than 30 years in the medical device industry. Recently Dr. Moore was Global Head, Refractive R&D for Abbott Medical Optics, a Division of Abbott Laboratories. Prior to Abbott, he worked for Medtronic in several key senior leadership roles in their Cardiac Rhythm Disease Management Business and was also VP R&D and board member for Smith and Nephew Endoscopy . Dr. Moore also held  several key leadership positions at Johnson & Johnson within their clinical diagnostics business.

Randy head shot.jpg

Randy Myer

Managing Director, Carolina Angel Network 

Mr. Myer is Managing Director of the Carolina Angel Network. He is a professor at the Kenan-Flagler Business School on the University of North Carolina Chapel Hill campus.  He is an investor in two venture capital funds, a private equity fund and two RTP angel groups as well as one in Seattle. He is a Board member of the Carolina Research Venture Fund. He is a current Board member and former Exec Committee member of the NC School of Science & Math. He is a former Board member and Chair of NC Idea, a foundation devoted to funding early stage companies and programs in North Carolina.


Chad Pearson

SVP, Wealth Management, Senior Portfolio, Portfolio Management Program, UBS

Chad Pearson leads the Pearson Patterson Smith Wealth Management group in providing wealth management and succession strategies for small business owners and their families. He began his finance career with Merrill Lynch in NYC in 1992. Chad is a CERTIFIED FINANCIAL PLANNER™ (CFP®) since 2004, and became a Certified Exit Planning Advisor (CEPA) in 2018.  Chad assists clients in integrating an exit strategy into the individual and financial goals of the business owner, while focusing on the components of maximizing business value and worth, individual financial planning, and life after business. Chad currently serves on the board of First Tee. He is a past board member of the Landfall Foundation Board and the NHRMC Foundation Board.

Kevin Schimelfening_Color - Mary Gross.jpg

Kevin J. Schimelfenig

Founder and Managing Partner, McGeever Family Office

Kevin is the Founder and Managing Partner of the McGeever Family Office, which focuses on achieving the financial and philanthropic goals of the family. McGeever’s investment portfolio places an emphasis on Healthcare, but also includes Technology, Energy and Real Estate. To support the success of McGeever’s investments, Kevin founded SalesForce4Hire, a company that provides strategic commercialization solutions for medical device, diagnostics, biopharma and information technology companies and their investors. SalesForce4Hire has played an instrumental role in the successful implementation of customized sales solutions with Fortune 500 and startup companies. Kevin is also an active angel investor who enjoys working closely with CEOs and leadership teams on strategic partnering and commercialization activities. He serves on several boards and is the Executive Chairman for Physcient (a North-Carolina based medical device company developing a blunt dissection tool for surgery).

Head shot - use this - Glenn Snyder.jpg

Glenn Snyder

Principal, Medtech Practice Leader, Deloitte LLP

A principal since 1998, Glenn is doing his "dream job" leading Deloitte's MedTech practice as it combines his roots as a mechanical engineer with his early consulting experience leading hospital clinical transformation programs. The med tech sector is positioned to be a substantial transformational force for the healthcare industry, harnessing the power of exponentials through sensor technology and augmented intelligence. However, it must adapt to new buying processes, higher "value" expectations, and a changing global regulatory and reimbursement environment.

SCT CEO Headshot - Sam Tetlow.JPG

Sam Tetlow

Founder & CEO, Grant Engine

Sam Tetlow is CEO of Grant Engine and Chairman of BioFluidica. Grant Engine delivers non-dilutive funding to leading life science companies through NIH, DoD, DARPA, and other sources. Sam continues to build on his venture capital experience by investing into compelling companies. Sam has successful experience as an entrepreneur and investor in life sciences companies such as EpiCypher (named best University Startup of 2016 by U.S. Congress), ILS Genomics (acq. LabCorp), Immunologix (acq. Intrexon), and Tranzyme Pharma (IPO) among others.

Brian Wagner Photo 3.jpg

Brian Wagner

Chief Digital Marketing and Operations Officer, GE Healthcare

Brian J. Wagner is Chief Digital Marketing and Operations Officer for GE Healthcare.  Prior to joining GE Healthcare, Brian founded Health Insights Consulting Group, Inc. Brian has served as Chief Commercial Officer for CAS Medical Systems, Inc. and also served as Senior Vice President and Chief Marketing Officer for Philips Imaging Systems.  Brian also held a series of executive management positions at Kimberly-Clark Health Care, now known as Halyard Health, including General Manager of the Global Pain and Temperature Management Division and Vice President of Global Strategic Marketing and Business Development. His experience also includes serving as Vice President and General Manager of Rubbermaid Healthcare, a medical division which he developed and launched, focusing on electronic medical administrative records.